USPExecution MethodologyStandard
USP <1058>

Analytical Instrument Qualification

Provides a framework for the qualification of analytical instruments used in pharmaceutical testing, covering Design Qualification (DQ), Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ) with an additional specification for computerised instruments.

LAST REVISED
May 2017
PRODUCT AREAS
SterileSolid DoseApiBiotech

What this does not cover

stated in the document's own scope
  • Qualifies the analytical instrument; validating the analytical procedure run on it is the subject of USP <1225>.
  • Provides an informational framework, not mandatory pass/fail acceptance criteria — those come from the applicable method, monograph, or quality system.
  • Addresses instrument suitability, not the broader computerised-system validation lifecycle covered by GAMP 5 and Annex 11.
SOURCE & PROVENANCE
ISSUING BODY
United States Pharmacopeia
JURISDICTION
United States / International
DOCUMENT ID
USP <1058>
Official site — United States Pharmacopeia

Always verify against the current published text before relying on it for a submission or inspection.

Overview

USP General Chapter <1058>, Analytical Instrument Qualification, is the compendial framework for demonstrating that an analytical instrument is fit for its intended use. It introduced the four-phase model that laboratories now organise their qualification around — Design Qualification, Installation Qualification, Operational Qualification, and Performance Qualification (the 4Qs) — and it sets out the roles and responsibilities that sit behind them. The chapter also introduced a risk-based instrument-classification scheme (Groups A, B, and C) that scales the effort to the instrument, and it draws the boundary between qualifying the instrument and validating the analytical method run on it.

Scope & applicability

All analytical instruments used for quality control testing of pharmaceutical products, including HPLC, UV-Vis, IR/FTIR, dissolution apparatus, Karl Fischer titrators, and particle size analysers.

Legal basis & how it acquires force

Chapter <1058> is part of the United States Pharmacopeia–National Formulary (USP–NF). Its number is above 1000, so it is informational rather than mandatory in its own right — it becomes an expectation when a monograph, another applicable requirement, or a laboratory’s own quality system calls it into force. In the United States, USP–NF standards are recognised under the Federal Food, Drug, and Cosmetic Act where they apply, so instrument qualification is read alongside the GMP requirement that laboratory equipment be suitable and controlled.

Document structure

PartCovers
Design Qualification (DQ)Documenting that the selected instrument is suitable for its intended purpose before purchase
Installation Qualification (IQ)Confirming the instrument is received and installed as specified in the intended environment
Operational Qualification (OQ)Demonstrating the instrument functions across its intended operating ranges
Performance Qualification (PQ)Verifying the instrument performs for the intended application over ongoing use
Roles and instrument classificationResponsibilities of users, quality, and manufacturers, and the Group A/B/C risk-based scheme

Key requirements

  • Risk-based instrument categorisation: Group A (standard instruments), Group B (specified instruments), Group C (computerised instruments)
  • DQ → IQ → OQ → PQ lifecycle with documented acceptance criteria
  • Re-qualification programme triggered by: relocation, major maintenance, service, anomalous results
  • Vendor qualification for Group C instruments

Revision notes

Current revision 2017. Stable guidance — no changes anticipated.

CHECKING ACCESS

Checking your Professional access…

Where this control fails

live FDA enforcement
See all FDA enforcement →

Live FDA recalls SPEQ maps to this standard’s topics — a SPEQ interpretation, not an FDA classification.

International alignment

Chapter <1058> is the compendial companion to analytical method validation in USP <1225> and to the GMP equipment expectations in 21 CFR 211.63 and 211.68 — qualification establishes the platform, validation establishes the method. For instruments with firmware or software, it dovetails with computerised-system approaches such as GAMP 5 and 21 CFR Part 11. The 4Q language it popularised is broadly recognised internationally even where a jurisdiction does not cite the chapter directly.

USP <1058>: frequently asked questions

Quick answers to common questions about USP <1058>.

What are the 4Qs in USP <1058>?

Design Qualification, Installation Qualification, Operational Qualification, and Performance Qualification. Together they demonstrate that an analytical instrument is suitable for its intended use across selection, installation, function, and ongoing performance.

Is USP <1058> mandatory?

On its own it is informational — USP general chapters numbered above 1000 are not mandatory unless invoked. In practice it is applied because GMP requires laboratory equipment to be suitable and controlled, and <1058> is the recognised framework for showing that.

What is the difference between instrument qualification and method validation?

Qualification under <1058> shows the instrument works to specification; method validation under <1225> shows the analytical procedure performed on it is fit for purpose. The instrument is the platform; the method is what runs on it.